Elevance Health Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Elevance Health ha aumentado sus beneficios a una tasa media anual de 8.5%, mientras que los beneficios de la industria de Healthcare han experimentado un crecimiento de 7.1% anual. Los ingresos han ido creciendo a una tasa media de 12.5% al año. La rentabilidad financiera de Elevance Health es de 15.3%, y sus márgenes netos son de 3.6%.

Información clave

8.5%

Tasa de crecimiento de los beneficios

10.4%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare	8.5%
Tasa de crecimiento de los ingresos	12.5%
Rentabilidad financiera	15.3%
Margen neto	3.6%
Última actualización de beneficios	31 Mar 2024

Actualizaciones de resultados anteriores recientes

Recent updates

We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation

May 09

Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors

Apr 01

Elevance: A Healthy Dose Of Dividend Growth

Mar 21

Elevance Heath: Financial Growth And Technical Strength Indicate A Buy

Mar 07

Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63

Feb 19

Elevance Health: Time To Buy This Incredible Dividend Growth Stock

Jan 26

Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement

Jan 19

Is Elevance Health (NYSE:ELV) A Risky Investment?

Jan 02

Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story

Dec 18

A Look At Elevance's Margin Dynamics

Nov 23

Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?

Nov 16

Elevance Health: A High Conviction Defensive Blue Chip Buy

Oct 19

These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely

Oct 04

Elevance: Pave The Way For The Next UnitedHealth

Sep 21

Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital

Sep 18

Here's The Price I Would Buy Elevance Health Stock

Sep 13

If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity

Aug 18

Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

Aug 04

Narrowing Down High-Quality Dividend Growth: Elevance Health Is Elemental

Jul 24

Elevance Health: Beaten Down Share Price Offers Solid Potential

Jul 10

Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly

Jul 05

Elevance Health: A Critical Update (Rating Downgrade)

Jun 05

Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

Jun 04

Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

May 05

We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt

Apr 04

Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.48

Feb 17

Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital

Feb 13

Elevance Health: Attractive On Its Expansion Catalysts

Feb 09

Elevance Health (NYSE:ELV) Has Announced That It Will Be Increasing Its Dividend To $1.48

Jan 28

Elevance Health acquiring Blue Cross and Blue Shield of Louisiana

Jan 23

Elevance Health Offers Great Value

Jan 17

At US$483, Is Elevance Health Inc. (NYSE:ELV) Worth Looking At Closely?

Jan 17

Elevance Health: Strong And Steady EPS Growth Ahead, High Relative Strength Name

Jan 02

Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly

Nov 28

Does Elevance Health (NYSE:ELV) Deserve A Spot On Your Watchlist?

Nov 16

Elevance Health to acquire speciality pharmacy from CarepathRx

Nov 09

Elevance Health (NYSE:ELV) Is Doing The Right Things To Multiply Its Share Price

Nov 02

Elevance Health declares $1.28 dividend

Oct 19

Are Investors Undervaluing Elevance Health Inc. (NYSE:ELV) By 37%?

Oct 12

Elevance affiliates to offer affordable Medicare Advantage plans

Oct 10

Molina, Elevance, Centene win Medicare contracts in California

Aug 26

Elevance Health (NYSE:ELV) Seems To Use Debt Rather Sparingly

Aug 25

Elevance Health: Continues To Grow, A Strong Buy

Aug 18

What Does Elevance Health Inc.'s (NYSE:ELV) Share Price Indicate?

Aug 13

Desglose de ingresos y gastos

Cómo gana y gasta dinero Elevance Health. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

NYSE:ELV Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Mar 24	171,745	6,244	36,666
31 Dec 23	171,340	5,987	36,236
30 Sep 23	168,626	6,127	35,704
30 Jun 23	165,716	6,441	33,539
31 Mar 23	160,676	6,094	31,749
31 Dec 22	156,599	5,894	30,696
30 Sep 22	153,251	6,166	29,605
30 Jun 22	149,134	6,072	28,496
31 Mar 22	144,353	6,228	27,590
31 Dec 21	138,643	6,158	26,604
30 Sep 21	133,883	5,518	26,357
30 Jun 21	129,219	4,231	25,839
31 Mar 21	124,632	4,714	25,675
31 Dec 20	121,868	4,572	25,202
30 Sep 20	117,449	4,955	23,013
30 Jun 20	112,965	5,916	20,850
31 Mar 20	109,167	4,779	17,955
31 Dec 19	104,212	4,807	15,356
30 Sep 19	100,165	4,298	14,323
30 Jun 19	96,742	4,074	13,706
31 Mar 19	94,220	3,989	13,758
31 Dec 18	92,091	3,750	14,020
30 Sep 18	91,409	4,556	13,681
30 Jun 18	90,584	4,344	13,146
31 Mar 18	90,061	4,145	12,772
31 Dec 17	90,049	3,843	12,650
30 Sep 17	89,055	2,980	12,520
30 Jun 17	88,038	2,851	12,634
31 Mar 17	87,083	2,777	12,549
31 Dec 16	84,862	2,470	12,559
30 Sep 16	83,364	2,282	12,562
30 Jun 16	81,866	2,319	12,518
31 Mar 16	80,412	2,398	12,590
31 Dec 15	79,158	2,560	12,535
30 Sep 15	77,959	2,886	12,299
30 Jun 15	76,605	2,862	12,187
31 Mar 15	75,066	2,734	12,032
31 Dec 14	73,886	2,560	11,748
30 Sep 14	72,792	2,362	11,361
30 Jun 14	72,090	2,385	10,936
31 Mar 14	71,307	2,453	10,485
31 Dec 13	71,024	2,634	9,953
30 Sep 13	68,443	2,785	9,487
30 Jun 13	65,941	2,823	9,023

Ingresos de calidad: ELV tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio(3.6%) de ELV son inferiores a los del año pasado (3.8%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de ELV han crecido un 8.5% al año en los últimos 5 años.

Acelerando crecimiento: El crecimiento de los beneficios de ELV en el último año (2.5%) está por debajo de su media de 5 años (8.5% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de ELV en el último año (2.5%) no superó al de la industria Healthcare 7.3%.

Elevance Health Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Información clave

Actualizaciones de resultados anteriores recientes

First quarter 2024 earnings: EPS misses analyst expectations

Elevance Health, Inc. to Report Q1, 2024 Results on Apr 18, 2024

Full year 2023 earnings: EPS misses analyst expectations

Full year 2023 earnings: EPS misses analyst expectations

Elevance Health, Inc. to Report Q4, 2023 Results on Jan 24, 2024

Third quarter 2023 earnings: EPS misses analyst expectations

Recent updates

We Think Shareholders Will Probably Be Generous With Elevance Health, Inc.'s (NYSE:ELV) CEO Compensation

Insider recently sold US$6.8m worth of stock

Elevance Health (NYSE:ELV) Has Announced A Dividend Of $1.63

Elevance Health: It's Not Too Late To Buy Their Dividend Growth

First quarter dividend of US$1.63 announced

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2024

First quarter 2024 earnings: EPS misses analyst expectations

Is Elevance Health (NYSE:ELV) Using Too Much Debt?

Elevance Health: Not Doing Enough In 2024 To Justify Premium Price

Elevance Health, Inc. to Report Q1, 2024 Results on Apr 18, 2024

StanCorp Financial Group, Inc. completed the acquisition of Life & Disability business of Elevance Health, Inc.

Elevance Health, Inc.'s (NYSE:ELV) Earnings Haven't Escaped The Attention Of Investors

Elevance: A Healthy Dose Of Dividend Growth

Insider recently sold US$1.2m worth of stock

Elevance Heath: Financial Growth And Technical Strength Indicate A Buy

Insider notifies of intention to sell stock

Upcoming dividend of US$1.63 per share

Full year 2023 earnings: EPS misses analyst expectations

Elevance Health (NYSE:ELV) Will Pay A Larger Dividend Than Last Year At $1.63

Elevance Health, Inc., Annual General Meeting, May 15, 2024

Fourth quarter dividend increased to US$1.63

Elevance Health: Time To Buy This Incredible Dividend Growth Stock

Elevance Health, Inc. Declares Quarterly Cash Dividend, Payable on March 22, 2024

Full year 2023 earnings: EPS misses analyst expectations

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2024

Slowing Rates Of Return At Elevance Health (NYSE:ELV) Leave Little Room For Excitement

Elevance Health, Inc. to Report Q4, 2023 Results on Jan 24, 2024

Elevance Health Addresses Healthcare’S Digital Divide by Increasing Access to High-Quality Smartphones and Health-Related Digital Services

Is Elevance Health (NYSE:ELV) A Risky Investment?

Elevance Health, Inc.'s (NYSE:ELV) Shares Not Telling The Full Story

Insider notifies of intention to sell stock

Upcoming dividend of US$1.48 per share at 1.2% yield

A Look At Elevance's Margin Dynamics

Is It Time To Consider Buying Elevance Health, Inc. (NYSE:ELV)?

Third quarter 2023 earnings: EPS misses analyst expectations

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2023

Elevance Health: A High Conviction Defensive Blue Chip Buy

Elevance Health, Inc. to Report Q3, 2023 Results on Oct 18, 2023

These 4 Measures Indicate That Elevance Health (NYSE:ELV) Is Using Debt Safely

Elevance: Pave The Way For The Next UnitedHealth

Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital

Here's The Price I Would Buy Elevance Health Stock

Upcoming dividend of US$1.48 per share at 1.3% yield

If EPS Growth Is Important To You, Elevance Health (NYSE:ELV) Presents An Opportunity

Elevance Health, Inc. Announces Executive Changes

Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

Narrowing Down High-Quality Dividend Growth: Elevance Health Is Elemental

Elevance Health, Inc. Provides Earnings Guidance for the Full Year 2023

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Elevance Health: Beaten Down Share Price Offers Solid Potential

Here's Why Elevance Health (NYSE:ELV) Can Manage Its Debt Responsibly

Elevance Health, Inc. to Report Q2, 2023 Results on Jul 19, 2023

Elevance Health: A Critical Update (Rating Downgrade)

Elevance Health's (NYSE:ELV) Returns On Capital Are Heading Higher

Upcoming dividend of US$1.48 per share at 1.3% yield

Is Now The Time To Look At Buying Elevance Health, Inc. (NYSE:ELV)?

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

We Think Elevance Health (NYSE:ELV) Can Stay On Top Of Its Debt

Upcoming dividend of US$1.48 per share at 1.3% yield

Elevance Health, Inc., Annual General Meeting, May 10, 2023

Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.48

Elevance Health Inc. (NYSE:ELV) completed the acquisition of BioPlus Specialty Pharmacy Services, LLC from CarepathRx.

Elevance Health (NYSE:ELV) Is Experiencing Growth In Returns On Capital

Elevance Health: Attractive On Its Expansion Catalysts

Elevance Health (NYSE:ELV) Has Announced That It Will Be Increasing Its Dividend To $1.48

Full year 2022 earnings: EPS misses analyst expectations

Elevance Health Inc. Provides Earnings Guidance for the Fiscal Year 2023

Elevance Health Inc. (NYSE:ELV) entered into a definitive agreement Louisiana Health Service and Indemnity Company.

Elevance Health acquiring Blue Cross and Blue Shield of Louisiana